Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL6045737 | 0.98 | MEN1 (0.41) | ACHEMEN1KMT2ACYP2D6ATM | |
| SCHEMBL6045421 | 0.93 | CYP2D6 (0.44) | ACHECYP2D6 | |
| SCHEMBL6045627 | 0.92 | ACHE (0.38) | ACHEMEN1KMT2ACYP2D6 | |
| SCHEMBL6045636 | 0.92 | DRD4 (0.44) | MEN1KMT2ACYP2D6 | |
| Oxalic Acid SCHEMBL6045529 | 0.92 | CYP2D6 (0.42) | ACHECYP2D6 | |
| SCHEMBL6045587 | 0.90 | ACHE (0.49) | ACHEMEN1KMT2ACYP2D6 | |
| SCHEMBL6045538 | 0.90 | CYP3A4 (0.42) | ACHEMEN1KMT2ACYP2D6 | |
| Fumaric Acid SCHEMBL6045576 | 0.89 | SIGMAR1 (0.41) | ACHECYP2D6 | |
| Fumaric Acid SCHEMBL6045570 | 0.89 | SIGMAR1 (0.41) | ACHECYP2D6 | |
| SCHEMBL6045430 | 0.89 | CHRM4 (0.42) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060252797-A1 | Receptor regulator | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-11-09 | — | — | US | claimed |
| EP-1559428-A1 | RECEPTOR REGULATOR | Takeda Pharmaceutical Company Limited (JP) | 2005-08-03 | — | — | EP | claimed |
| US-20060252797-A1 | Receptor regulator | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-11-09 | — | — | US | disclosed |
| EP-1559428-A1 | RECEPTOR REGULATOR | Takeda Pharmaceutical Company Limited (JP) | 2005-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252797-A1 | Receptor regulator | NMUR1, NMUR2, NMBR | ACHE 3383/4885MEN1 215/4885KMT2A 2790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.